KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) EBT Margin (2016 - 2025)

Globus Medical's EBT Margin history spans 15 years, with the latest figure at 20.48% for Q4 2025.

  • For Q4 2025, EBT Margin rose 1673.0% year-over-year to 20.48%; the TTM value through Dec 2025 reached 20.59%, up 1580.0%, while the annual FY2025 figure was 20.59%, 1580.0% up from the prior year.
  • EBT Margin reached 20.48% in Q4 2025 per GMED's latest filing, up from 18.72% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.76% in Q2 2022 to a low of 1.42% in Q1 2024.
  • Average EBT Margin over 5 years is 16.42%, with a median of 19.99% recorded in 2025.
  • The largest YoY upside for EBT Margin was 3423bps in 2021 against a maximum downside of -2914bps in 2021.
  • A 5-year view of EBT Margin shows it stood at 9.7% in 2021, then surged by 149bps to 24.17% in 2022, then tumbled by -83bps to 4.05% in 2023, then decreased by -7bps to 3.75% in 2024, then soared by 446bps to 20.48% in 2025.
  • Per Business Quant, the three most recent readings for GMED's EBT Margin are 20.48% (Q4 2025), 18.72% (Q3 2025), and 25.25% (Q2 2025).